Mifepristone as Bridge or Adjunct Therapy in the Management of Challenging Cushing Disease Cases

por Chang, Alice Y, Mirfakhraee, Sasan, King, Elizabeth E, Mercado, Jennifer U, Donegan, Diane M, Yuen, Kevin CJ
Publicado 2021

Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations

por Brown, David R., East, Honey E., Eilerman, Bradley S., Gordon, Murray B., King, Elizabeth E., Knecht, Laura A., Salke, Brandon, Samson, Susan L., Yuen, Kevin C. J., Yau, Hanford
Publicado 2020

Germline mutations in TMEM127 confer susceptibility to pheochromocytoma

por Qin, Yuejuan, Yao, Li, King, Elizabeth E., Buddavarapu, Kalyan, Lenci, Romina E., Chocron, E. Sandra, Lechleiter, James D., Sass, Meghan, Aronin, Neil, Schiavi, Francesca, Boaretto, Francesca, Opocher, Giuseppe, Toledo, Rodrigo A., Toledo, Sergio P. A., Stiles, Charles, Aguiar, Ricardo C. T., Dahia, Patricia L. M.
Publicado 2010